Deliver Your News to the World

(OTC: BANY) Markets New Electro-Diagnostic Testing Machine


(CybeRelease, May 4, 2006 ) - Lake Harmony, PA - Banyan Corporation (OTC BB: BANY) and Banyan Subsidiary Premier Medical Group Inc. has completed beta testing for the VT3000, a revolutionary new Electro-Diagnostic testing machine. Banyan has formed a new subsidiary, Virtual Medical Systems, to market the new machine and associated electro-diagnostic professional services. Electro-Diagnostic testing is used in diagnosing problems related to nerves, muscles, spinal cord or the brain. The VT3000 adds another revenue stream to Banyan in addition to significantly lowering our operating costs for diagnostic testing.

By owning their own VT3000, Doctors will be able to perform Nerve Conduction Velocity Tests on their patients, as indicated, in their own office thereby eliminating the inconvenience of sending their patients elsewhere. Virtual Medical Systems’ board certified physicians will interpret results of the tests and prepare a detailed report. The VT3000 also features Live Viewing technology whereby our nationally registered technicians, and many times board certified physicians, view the test live to support and assist the Doctor in real time to ensure quality testing.

Commenting on the new VT3000 and Virtual Medical Systems, Banyan CEO Michael Gelmon said, “We have developed a revolutionary and extremely cost effective electro-diagnostic testing machine. With a VT3000 in their office, Doctors can better serve the needs of their patients with timely testing and results. Sales of the VT3000 also adds a new revenue stream to Banyan and improves our operating costs.”
For more information on Chiropractic USA, Diagnostic USA, and Premier Medical Group contact Banyan Corporation Investor Relations toll-free at (800) 808-0899 or visit

CybeRelease Gainers are Crocs, Inc. (Nasdaq: CROX), Gulfport Energy Corporation (Nasdaq: GPOR), Universal Forest Products, Inc. (Nasdaq: UFPI), Olympic Steel, Inc. (Nasdaq: ZEUS), KLA-Tencor Corporation (Nasdaq: KLAC), Tower Group, Inc. (Nasdaq: TWGP), Jos. A. Bank Clothiers, Inc. (Nasdaq: JOSB) and UAL Corporation (Nasdaq: UAUA).

CybeRelease Decliners are Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), Electro-Sensors, Inc. (Nasdaq: ELSE), Greenfield Online, Inc. (Nasdaq: SRVY), US LEC Corp. (Nasdaq: CLEC), Pacer International, Inc. (Nasdaq: PACR), Westaim Corporation (The) (Nasdaq: WEDX), SeaBright Insurance Holdings, Inc. (Nasdaq: SEAB) and Lexicon Genetics Incorporated (Nasdaq: LEXG).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $595.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.